Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... concluded: "Our findings indicate that treatment with PZQ ameliorates hepatic schistosomiasis pathology even in mice fed a low-protein diet." Barros and colleagues ...
2009 NOV 10 ... Furthermore, Sj13 showed a good antigenicity when reacted with saliva or serum from schistosomiasis patients. The recombinant Sj13 (rSj13) expressed and purified from Escherichia coli was ...
2009 OCT 19 ... "Simultaneous occurrence of brain tumor and myeloradiculopathy in cases of Manson's schistosomiasis have only rarely been described. We report the case of a 38-year-old man who developed ...
2009 OCT 12 ... (The presumptive treatment of all school-aged children is the least costly strategy for schistosomiasis control in Plateau and Nasarawa states, Nigeria. Annals of Tropical Medicine and ...
2009 OCT 5 ... Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Malaria, Schistosomiasis and Filariasis, Shanghai 200025, China. Publisher contact information for ...
2009 OCT 12 ... the intermediate host snail of Schistosoma japonicum, might facilitate more effective schistosomiasis control. We selected 12 villages in a mountainous area of Eryuan County, Yunnan ...
2009 NOV 16 ... blindness worldwide, elephantiasis, leprosy, dengue fever, hookworm infection and schistosomiasis. World spending to battle such illnesses, however, amounts to a relative drop in the ...
2009 OCT 5 ... the United States, "The near exclusive use of praziquantel (PZQ) for treatment of human schistosomiasis has raised concerns about the possible emergence of drug-resistant schistosomes. We ...
2009 NOV 16 ... "Schistosomal myeloradiculopathy (SMR) is the most severe and disabling form of schistosomiasis. The diagnosis is based on clinical, laboratory, and image data," investigators in Belo ...
2009 OCT 5 ... and may represent an attractive therapeutic target for the treatment and control of schistosomiasis." Swierczewski and colleagues published the results of their research in ...
2009 SEP 14 ... evaluated the potential of parasite GSTs as vaccine candidates especially against schistosomiasis, fascioliasis and Seteria cervi. However, vaccine potential of GSTs of lymphatic ...
2009 SEP 14 ... "Praziquantel (PZQ) is the only widely available drug to treat schistosomiasis. Given the potential for drug resistance, it is prudent to search for novel ...
2009 OCT 5 ... full blood count, Mantoux, vitamin D level, hepatitis B serology, syphilis serology, Schistosomiasis serology and malarial antigens. There were 239 patients, the majority (75%) from Africa, ...
2009 NOV 3 ... whether a long-term high-fat diet has an effect on the outcome of chronic murine schistosomiasis mansoni compared to a standard diet. Swiss Webster female mice (3 weeks old) were fed ...
2009 OCT 12 ... a new molluscicide that could give effective and environmentally-friendly control of schistosomiasis in humans and livestock," wrote F.C. Zou and colleagues. The researchers ...
2009 NOV 23 ... injury. The objective of this study was to evaluate the potential link between hepatic schistosomiasis and bile duct injury in relation to the expression of profibrotic cytokines and ...
2009 SEP 15 ... T cells does not further affect transformation of BALB/c to a healer phenotype. in acute schistosomiasis, however, Lck(cre)Il4ra(-/lox) mice showed enhanced mortality compared with Il4ra(-/lox) ...
2009 NOV 10 ... T-bet-dependent signaling negatively regulates Th17-mediated immunopathology in severe schistosomiasis." Rutitzky and colleagues published their study in European Journal of ...
